Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Is (CVS) Outperforming Other Retail-Wholesale Stocks This Year?

Is CVS Health (CVS) Stock Outpacing Its Retail-Wholesale Peers This Year?

CVS Health is trading at a solid discount, leaving enough upside for a compelling return.

CVS: More Than Just A Retirement Stock

CVS Health (CVS) closed the most recent trading day at $84.28, moving -0.11% from the previous trading session.

CVS Health (CVS) Stock Moves -0.11%: What You Should Know

Anthem

Catalent

Medtronic

Pfizer

Teladoc

UnitedHealth Group

Healthcare stocks could take over from energy stocks as top dog during this defensive cycle as yields move higher and tech stocks lose value. The post 7 Healthcare Stocks to Add to Your Portfolio appeared first on InvestorPlace.

7 Healthcare Stocks to Add to Your Portfolio

We think that CVS Health stock currently is a better pick compared to Walgreens Boots Alliance stock, despite Walgreens revenue growing at a faster pace over the last twelve month period. CVS trades at about 0.4x trailing revenues, compared to 0.3x for Walgreens.

This Stock Is Likely A Better Pick Over Walgreens Boots Alliance

CVS Health (CVS) closed at $83.81 in the latest trading session, marking a -0.31% move from the prior day.

CVS Health (CVS) Stock Moves -0.31%: What You Should Know

Walgreens

Walmart

Four large pharmacy chains, including Walgreens Boots Alliance Inc (NYSE: WBA), CVS Health Corp (NYSE: CVS), Walmart Inc (NYSE: WMT), and Giant Eagle Inc, will face their first trial over the U.S. opioid epidemic, Reuters reported. The Ohio counties of Lake and Trumbull allege that oversight failures led to excessive amounts of opioid pills in their communities.

After Drug Distributors, Now Pharmacy Chains Face Trial In US Opioid Litigation: Reuters

WOONSOCKET, R.I., Oct. 1, 2021 /PRNewswire/ -- CVS Health Corporation ("CVS Health") (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, November 3, 2021, at 8:00 a.m.

CVS Health To Hold Third Quarter 2021 Earnings Conference Call

HARTFORD, Conn., Oct. 1, 2021 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), announced its 2022 Medicare offerings, featuring expanded benefits focused on a holistic approach to health and new Medicare Advantage plan options, including Dual Eligible Special Needs Plans and Aetna Medicare Eagle® plans designed especially for Veterans in additional states.

Aetna 2022 Medicare plans feature more benefits, lower member costs and greater affordability

Pharmacy giant CVS Health Corporation (NYSE:CVS) has played an integral in vaccine and Covid-19 testing facilitation.

CVS Stock Boosted by Latest Vaccine Developments

Apple

Abbott Labs

Amplify Lithium & Battery Technology ETF

Blackrock Inc

Carrier Global

Colgate-Palmolive

Chevron

Invesco DB Commodity Index Tracking Fund

General Electric

iShares Core S&P 500 ETF

Johnson & Johnson

Coca-Cola

Lowe's

Microsoft

NIKE

ProShares S&P 500 Dividend Aristocrats ETF

Otis Worldwide

PepsiCo

Procter & Gamble

QUALCOMM

Raytheon Technologies

Texas Instruments

Vanguard Dividend Appreciation ETF

Exxon Mobil

The Dividend Aristocrats have historically beat the market with less volatility. Can you improve your odds by paying attention to certain metrics such as quality or safety?

Going One Better Than The Dividend Aristocrats

LTC Properties

Veeva Systems

Don't miss out on these solid picks for your investment portfolio.

3 No-Brainer Stocks to Buy in the Healthcare Sector

U.S. Bancorp

History may not be investors' friend in the near term, but it's one of their greatest long-term allies.

Is a Stock Market Crash Looming? Here's What the Data Says You Should Be Focused On

WOONSOCKET, R.I., Sept. 24, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that, following approval from the Centers for Disease Control and Prevention (CDC) based on guidance from the organization's Advisory Committee on Immunization Practices (ACIP), select CVS Pharmacy and MinuteClinic locations are now offering the Pfizer-BioNTech COVID-19 booster shot to eligible populations beginning today, Friday, September 24.

CVS Health Announces Availability of Pfizer-BioNTech Booster Shot to Eligible Populations

CVS Health's (CVS) retail business sees solid rebound in front-store sales with strength across all categories.

CVS Health (CVS) Retail Business Grows Despite Cost Pressure

The nation's obsession with pets shows no signs of abating, to judge by results from CVS Group PLC. The company, one of the UK's leading providers of integrated veterinary services, saw full year revenues rise 19.2% to £510.1mln, with strong organic growth and also contributions from nine acquisitions.

CVS benefits from boom in pets during lockdown

American Well Corporation

Ginkgo Bioworks Holdings

Talkspace

Welltower

Thanks to the coronavirus pandemic, many people are rethinking the medical sector, boding well for healthcare stocks. The post 7 Healthcare Stocks to Buy Now as the Pandemic Forces a Rethink appeared first on InvestorPlace.

7 Healthcare Stocks to Buy Now as the Pandemic Forces a Rethink

In the latest trading session, CVS Health (CVS) closed at $84.58, marking a -1.09% move from the previous day.

CVS Health (CVS) Stock Moves -1.09%: What You Should Know

CVS Health Corp. CVS, +0.19% will be hosting a national hiring event on September 24 in which the pharmacy retailer will seek 25,000 retail and clinical hires, including nurses and pharmacists. CVS is preparing for the coming demand for flu shots, COVID boosters and ongoing demand for COVID vaccines.

CVS invites candidates to text to start application process as it seeks 25,000 workers

CVS Health Corp said on Monday it would fill as many as 25,000 clinical and retail jobs ahead of the flu season and as the United States prepares to administer booster COVID-19 vaccine shots.

CVS Health to hire 25,000 ahead of flu season, COVID-19 boosters

WOONSOCKET, R.I., Sept. 20, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that it is recruiting qualified candidates to fill 25,000 clinical and retail jobs during a one-day national career event on Friday, September 24.

CVS Health to Hire 25,000 Across the U.S. During One-Day Virtual Career Event

CVS Health plans to hire 25,000 new pharmacy and drugstore workers as the U.S. prepares for seasonal flu season and a rush to get Covid-19 booster shots.

CVS To Hire 25,000 As U.S. Preps Covid Booster Shots

CVS Health Corporation remains extremely undervalued and represents one of the best investment opportunities available in the current frothy market. The market has begun to appreciate CVS in 2021, but substantial upside remains and is likely to be unlocked sooner than you think.

CVS Health: Catalysts Ahoy

CVS's ready and personal care services the structural shift we saw in healthcare consumers.

CVS: Look At The Bigger Picture

CVS Health improved its balance sheet and continues to improve its business. CVS is still deeply undervalued and trading at least 30% below its intrinsic value.

News for CVS Health Stock (CVS)